---
title: "Synovial Immune Control Failure in Osteoarthritis: From Homeostasis to Inflammatory Niche Formation"
id: "frontiers-in-immunology-14-synovial-immune-control-failure-in-osteoarthritis-from-maintenance-of-tissue"
canonical_url: "https://medichelpline.com/clinical-feed/frontiers-in-immunology-14-synovial-immune-control-failure-in-osteoarthritis-from-maintenance-of-tissue"
content_type: "clinical_feed_article"
specialty: "Rheumatology"
source_name: "Frontiers in Immunology"
source_url: "https://www.frontiersin.org/articles/10.3389/fimmu.2026.1889424"
published_at: "2026-08-31T00:00:00.000Z"
evidence_level: "Journal Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Synovial Immune Control Failure in Osteoarthritis: From Homeostasis to Inflammatory Niche Formation
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/frontiers-in-immunology-14-synovial-immune-control-failure-in-osteoarthritis-from-maintenance-of-tissue
- **Specialty:** [Rheumatology](https://medichelpline.com/clinical-feed/rheumatology.md)
- **Primary Source:** Frontiers in Immunology
- **Source URL:** [Original Journal Publication](https://www.frontiersin.org/articles/10.3389/fimmu.2026.1889424)
- **Published At:** 2026-08-31T00:00:00.000Z
- **Evidence Rating:** Journal Feed
## Executive GIST (TL;DR)
- The source article metadata (title, journal, and URL) was provided but the full article body was not included; detailed findings, methods, and conclusions were not reported in the source text. - The article title indicates a focus on **synovial immune control** in **osteoarthritis** and a transition from normal tissue homeostasis to formation of an **inflammatory niche**, but the source did not supply supporting content or data. - Because the full manuscript content was absent, specifics such as implicated cell types, molecular pathways, experimental evidence, patient data, and proposed interventions were not available from the source. - The available information permits only an outline of likely topics: definitions of synovial immune regulation, concepts of tissue homeostasis, mechanisms that could underlie immune control failure, characteristics of an inflammatory niche, and clinical implications; however these are inferred from the title, not reported results. - Any detailed claims about mechanisms, biomarkers, or therapeutic strategies are not reported in the provided source and therefore cannot be stated with certainty. - The article’s provenance is Frontiers in Immunology; the source URL and journal metadata were given but content retrieval failed or was incomplete in the supplied SOURCE JINA BODY. - Readers and clinicians should consult the full published article for validated data, experimental design, and specific clinical or translational recommendations because those details were not available in the provided source.
## Clinical Analysis & Structured Key Points
Frontiers | Synovial immune control failure in osteoarthritis: from maintenance of tissue homeostasis to inflammatory niche formation HYPOTHESIS AND THEORY article Front. Immunol. , 31 August 2026 Sec. Inflammation Volume 17 - 2026 | https://doi.org/10.3389/fimmu.2026.1889424 Published in Frontiers in Immunology Inflammation 7 impact factor 11.3 citescore Part of a Research Topic New Insights into Immunity in Musculoskeletal Disorders: Focusing on Bone, Joint, and Soft Tissue Pathologies 70k views 32 articles Editor & Reviewers Edited by B Z BAOCUN ZHANG Reviewed by K G Kannan Govindaraj C S Célia Seillier Outline Figures and Tables Figure 1 View in article Figure 2 View in article Figure 3 View in article HYPOTHESIS AND THEORY article Front. Immunol. , 31 August 2026 Sec. Inflammation Volume 17 - 2026 | https://doi.org/10.3389/fimmu.2026.1889424 Synovial immune control failure in osteoarthritis: from maintenance of tissue homeostasis to inflammatory niche formation K H Kangyi Hu 1 † Y S Yongjia Song 1 † J P Jiaxing Pan 1 Z W Zhiqiang Wang 1 W L Weiran Li 1 C Y Chaoqun Yan 1 Y X Yongpeng Xue 1 X J Xiao Jia 1 L Y Luhao Yu 1 M S Min Song 1 * +2 more J B Jiamin Bao 2 * 1. Clinical College of Traditional Chinese Medicine, Gansu University of Chinese Medicine, Lanzhou, China 2. School of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine, Shanghai, China Article metrics View details Abstract Osteoarthritis (OA) is a whole-joint disease involving cartilage, synovium, subchondral bone, and neurovascular structures. Synovitis, damage-associated molecular patterns, and interactions between macrophages and fibroblast-like synoviocytes have been widely studied. However, a tissue-level explanation is still lacking for how low-grade and fluctuating synovial responses become persistent inflammation. We therefore propose a framework of synovial immune control failure. In this framework, the synovium does more than participate in inflammation. By clearing intra-articular damage-related material, limiting the duration of inflammation, maintaining stromal homeostasis, and regulating the entry of peripheral immune cells, it helps determine whether local joint inflammation can return to a low-level state. When damage-related inputs persist and debris clearance, inflammatory resolution, and resetting of cellular states do not occur in parallel, macrophages, fibroblast-like synoviocytes, and the vascular-interstitial interface may form a mutually sustaining pathological cellular network. Disease-associated cellular states and their interactions may then be retained locally in the synovium, forming what this article defines as an inflammatory niche. This niche may form bidirectional feedback with cartilage degeneration and subchondral bone remodeling. However, the synovium is not the common initiating tissue in all patients with OA. This framework may be most relevant to disease subtypes with persistent or recurrent synovitis, myeloid cell activation, and abnormal stromal remodeling. We further discuss the evidence base, boundaries, testable predictions, and potential implications of this model for OA patient stratification and synovium-targeted intervention. 1 Introduction Osteoarthritis (OA) is a whole-joint disease involving articular cartilage, synovium, subchondral bone, and neurovascular structures. Its main pathological features include cartilage matrix degradation, abnormal subchondral bone remodeling, and osteophyte formation ( 1 , 2 ). However, structural degeneration alone cannot capture all clinical and biological features of OA ( 3 , 4 ). Some patients have long-standing low-grade synovial inflammation. Pain severity does not always match structural damage on imaging, and patients differ markedly in disease progression and treatment response ( 5 ). These observations indicate that OA is not a simple process of mechanical wear. It is a heterogeneous disease shaped by tissue injury, local inflammation, and failed repair. Synovitis is a common pathological feature of OA, but it varies greatly among individuals. Longitudinal imaging studies show that synovitis can appear before definite radiographic structural changes and is associated with later pain and structural progression ( 6 , 7 ). Recent single-cell sequencing and spatial omics studies further show disease-associated changes in the composition and states of macrophages, fibroblast-like synoviocytes (FLS), and other immune and stromal cells in OA synovium ( 8 , 9 ). These findings support a role for the synovium in maintaining OA inflammation and mediating tissue crosstalk. They do not prove that the synovium is the common initiating tissue in all patients with OA. The degree and duration of synovitis, and its relationship with cartilage and subchondral bone lesions, may differ among patients. Previous studies have described many pathological features of OA synovitis at the levels of inflammatory mediators, cell subsets, and signaling pathways. Yet the process by which low-grade, focal, and fluctuating synovial changes become persistent tissue inflammation remains poorly understood. Under physiological conditions, resident macrophages, FLS, and the vascular-interstitial interface in the synovium jointly participate in intra-articular debris clearance, maintenance of synovial-fluid and matrix environments, and regulation of immune-cell recruitment ( 10 ). These functions limit the intensity, duration, and spread of local inflammation. As mechanical loading, matrix injury, cell death, and metabolic stress continue to accumulate, synovial homeostatic functions may gradually become impaired. Low-grade inflammation may then shift from a transient injury response to a persistent pathological state. Based on these observations, this article proposes synovial immune control failure as a tissue-level framework for pathological transition. Under physiological or early injury conditions, resident macrophages, FLS, and the vascular-interstitial interface clear intra-articular damage-related material, maintain the local matrix environment, and restrict the spread of inflammation. In this way, low-level immune responses remain within a regulatable range. With persistent mechanical stress, tissue injury, and metabolic abnormalities, the ability of the synovium to restore homeostasis may gradually weaken. Macrophage clearance function, FLS states, and vascular-interstitial regulatory networks then change, promoting the transition from a transient and localized inflammatory response to persistent inflammation. During this process, abnormal cellular states and their interactions may become progressively stabilized in local synovial tissue and may form a pathological microenvironment that maintains inflammation and tissue remodeling. This microenvironment is referred to here as the synovial inflammatory niche. The following sections discuss this framework from the perspectives of the tissue basis of synovial immune homeostasis, the pathological process of immune control failure, inflammatory niche formation, and crosstalk with other joint tissues ( Figure 1 ). Figure 1 Proposed transition from a reversible synovial response to synovial immune control failure and inflammatory niche formation in OA. Under homeostatic conditions or during a reversible response to minor injury, resident synovial macrophages, fibroblast-like synoviocytes (FLS), and the vascular–interstitial interface cooperate to clear intra-articular debris, maintain the synovial-fluid and extracellular-matrix environment, and regulate the recruitment of circulating immune cells. When mechanical stress and tissue injury persist, continued generation of damage-related signals may coincide with impaired efferocytosis, delayed inflammatory resolution, altered macrophage and FLS states, endothelial activation, and prolonged myeloid-cell recruitment. Inflammasome activation and metabolic or mitochondrial stress may amplify inflammatory output under specific conditions. If these responses fail to resolve after the initiating damage input has diminished, disease-associated cellular states and their interactions may remain locally retained, forming what is proposed here as a synovial inflammatory niche. This niche may participate in reciprocal communication with cartilage and subchondral bone and thereby prolong synovial inflammation and tissue remodeling. The model does not imply that the synovium is the universal initiating tissue in osteoarthritis. The schematic is based on representative studies of resident synovial macrophages, macrophage clearance, FLS states, macrophage–FLS communication, and experimental modulation of synovial inflammation. Created with BioRender.com . 2 Tissue basis of synovial immune homeostasis The synovium consists of a lining layer facing the joint cavity and a sublining layer rich in vessels, stroma, and immune cells. Because it lacks a continuous basement membrane, the synovium is not a closed epithelial covering. It is an open interface connecting synovial fluid, periarticular tissues, and the peripheral circulation ( 11 , 12 ). Cellular debris, matrix wear products, and metabolites generated during joint motion can directly contact the synovial lining and exchange with deeper stroma through interstitial fluid and vascular networks. Synovial homeostasis therefore depends not only on which cells are present, but also on where they are located and how they relate to one another in different spatial regions. Single-cell sequencing studies show that macrophages, fibroblast-like synoviocytes (FLS), vascular endothelial cells, pericytes, and other immune cells in the synovium have clear regional distribution patterns ( 8 , 9 ). Cells in the lining layer directly process signals from the joint cavity, whereas the sublining layer supports stromal maintenance, material exchange, and cell migration. This spatial division provides a basis for understanding how the synovium maintains a relatively stable local environment during continuous mechanical loading and minor tissue wear. 2.1 The synovial lining interface: cooperation between resident macrophages and lining FLS The synovial lining layer is mainly composed of macrophage-like synoviocytes and FLS ( 13 ). Both cell types face synovial fluid directly, but they have different functions. Resident macrophages clear apoptotic cells, cartilage matrix fragments, and other intra-articular debris. Lining FLS synthesize lubricin, hyaluronic acid, and related matrix components, thereby maintaining synovial-fluid properties and a low-friction environment on the joint surface ( 14 – 17 ). This spatial proximity allows clearance of damage-related material and maintenance of the synovial-fluid environment to continue at the same tissue interface. The role of resident macrophages in the synovial lining is not limited to phagocytosis. In mouse joints, Culemann et al. found that CX3CR1+ resident synovial macrophages form a barrier-like structure along the lining layer and restrict the entry of peripheral inflammatory cells into the joint cavity during experimental arthritis ( 10 ). That study mainly used inflammatory arthritis models and does not directly prove that the same barrier mechanism exists in OA synovium. Even so, it suggests that tissue-resident macrophages may help maintain the joint boundary through stable spatial positioning and cell-cell connections. Single-cell studies of human OA synovium have identified different macrophage states with features related to tissue residence, phagocytic clearance, lipid handling, and immune regulation. Together with studies of healthy synovium and inflammatory joint disease, these findings show that molecules such as MERTK, CD163, FOLR2, and TREM2 can be present in some tissue-resident or immunoregulatory macrophage populations ( 18 – 20 ). These markers do not define a fixed category of protective macrophages, because their expression is affected by sampling site, disease stage, and the local environment. Current findings more appropriately indicate that OA synovial macrophages show clear state heterogeneity, and that some cells retain transcriptional features related to tissue maintenance and debris handling. Whether these cells gradually decrease or undergo functional changes during OA progression still lacks longitudinal observation and lineage-tracing evidence. Lining FLS also have clear regional features. FLS with high PRG4 and HAS1 expression are mainly distributed in the lining layer and are associated with lubricin production, hyaluronic acid synthesis, and synovial-fluid homeostasis ( 21 , 22 ). Synovial fibroblast atlas studies further show that PRG4-high lining FLS and THY1-high sublining FLS represent two major spatial and functional states, and that their molecular features can change with the tissue environment ( 23 , 24 ). It is reasonable to propose that lining FLS influence the distribution of injury products and cell contacts in the joint cavity by maintaining synovial fluid and the surface matrix environment. However, defining them directly as an independent immune barrier that blocks DAMP diffusion still requires more direct functional evidence. Thus, homeostasis at the synovial lining interface cannot be attributed to a single cell type. Resident macrophages mainly handle debris and maintain the tissue boundary, whereas lining FLS maintain synovial fluid and the surface matrix environment. Their spatial cooperation allows low-level injury inputs generated during joint motion to be processed promptly near the joint cavity. 2.2 The sublining layer: regulatory roles of stromal tissue and the vascular interface The sublining layer lies deep to the lining layer. It contains blood vessels, lymphatic vessels, FLS, macrophages, and other immune cells, and it is supported by extracellular matrix ( 25 , 26 ). Unlike the lining layer, which directly contacts synovial fluid, the sublining layer mainly provides tissue support, nutrient exchange, and cell migration, while connecting the local joint environment with the peripheral circulation. Sublining FLS have strong capacities for matrix production and maintenance of tissue structure. Single-cell studies often associate them with molecular features such as THY1/CD90, PDPN, COL1A1, and CXCL12 ( 16 , 27 , 28 ). These cells are mainly distributed around vessels and in deep stroma. By synthesizing and renewing extracellular matrix, they provide spatial support for vessels, immune cells, and other tissue components. Some sublining FLS also express chemokines involved in cell positioning and local communication, but their physiological role should not be equated simply with inflammatory cell recruitment. Under homeostatic conditions, these signals also help maintain normal cell distribution and intercellular connections within the tissue. The synovial lining layer itself is avascular, so tissue nutrition, oxygen supply, and metabolic waste clearance depend mainly on microvessels in the sublining layer. Endothelial cells, pericytes, and perivascular FLS maintain vascular structure and regulate permeability, leukocyte adhesion, and cell extravasation ( 29 , 30 ). Entry of circulating immune cells into the synovium is not completely blocked. It is regulated by local signals and vascular state. During low-level tissue injury, limited cell migration may contribute to clearance and repair. When the stimulus weakens, cell recruitment should also decline. The homeostatic function of the vascular-interstitial interface therefore lies mainly in coordinating local tissue needs with peripheral cell input, rather than forming an absolutely closed barrier. In addition to macrophages, the sublining layer can contain T cells, B cells, mast cells, dendritic cells, and other immune cells ( 31 ). Their number and composition differ markedly among individuals and joint regions. Current evidence does not establish a universal dominant role for any adaptive immune cell type in OA synovial homeostasis. However, these cells can communicate locally with FLS, macrophages, and perivascular cells and may influence how the tissue responds to injury. Overall, the synovial lining and sublining layers are not independent regions. The lining interface contacts and processes signals from the joint cavity, while the sublining layer maintains stromal structure and regulates exchange between local tissue and the peripheral circulation. Resident macrophages, spatially distinct FLS states, and vascular-associated cells thereby form a continuous tissue system. This system allows the joint to return to a relatively stable local state despite repeated low-level injury. The next section discusses which changes in these homeostatic functions may be sufficient to transform transient synovial responses into persistent inflammation ( Figure 2 ). Figure 2 Cellular architecture of the synovial immune control system. This schematic shows the spatial organization of the synovial immune control system. The synovium is organized into the joint cavity/synovial fluid compartment, the synovial lining layer, the synovial sublining layer, and the vascular-interstitial interface. In the joint cavity, low levels of cartilage debris, DAMPs, apoptotic fragments, hyaluronic acid, and lubricin are present under homeostatic conditions. In the lining layer, PRG4 + lining FLS and resident synovial macrophages form a functional barrier-like interface. PRG4 + FLS maintain lubricin and hyaluronic acid production, support matrix buffering, and protect the synovial surface, whereas resident macrophages clear debris and apoptotic cells, restrict DAMP accumulation, and maintain a low-inflammatory barrier. In the sublining layer, THY1 + /PDPN + sublining FLS, macrophages, T cells, and mast cells are embedded within the extracellular matrix and participate in immune coordination, chemokine buffering, and tissue remodeling potential. The vascular-interstitial interface, composed of endothelial cells, pericytes, and circulating immune cells, acts as a gatekeeper that regulates leukocyte entry and preserves immune homeostasis. Together, these spatially organized cellular compartments maintain a low-inflammatory joint microenvironment through clearance, buffering, immune coordination, and restricted immune cell trafficking. Created with BioRender.com . 3 Synovial immune control failure: from impaired homeostatic recovery to persistent inflammation DAMP-mediated innate immune activation, synovial macrophage heterogeneity, pathological FLS phenotypes, and their interactions have become major topics in current osteoimmunology research on OA. These studies mainly explain which cells and molecules participate in synovial inflammation. They less often distinguish a transient injury response from persistent inflammation that cannot terminate spontaneously. Increased inflammatory mediators, more immune cells, or synovial thickening can reflect the presence and degree of a local response. They do not show whether the synovium can restore homeostasis after the stimulus weakens. Compared with existing osteoimmunological frameworks, the synovial immune control failure model does not add a new inflammatory cell type or signaling pathway. Instead, it includes the reversibility of inflammation in pathological assessment. Similar degrees of synovial activation may have different outcomes. Some responses resolve as injury decreases, whereas others persist after the original stimulus has weakened. This article defines the latter condition as synovial immune control failure. In this state, after injury input declines, the synovium still cannot return promptly to a relatively stable low-inflammatory state. Its manifestations may include insufficient clearance of damage-related material, delayed inflammatory resolution, weakened homeostatic functions of resident cells, persistence of pathological cellular states, or prolonged abnormal immune-ce
## Related Clinical Research

- [Single-cell genomics in rheumatoid arthritis: from synovial niches to new therapies](https://medichelpline.com/clinical-feed/nature-immunology-2-immune-mediated-rheumatoid-arthritis-from-single-cell-genomics-to-new-therapies.md)
- [Effectiveness and Safety of Tocilizumab in Refractory Rheumatoid Arthritis: A Moroccan Study](https://medichelpline.com/clinical-feed/medrxiv-12-real-world-effectiveness-and-safety-of-tocilizumab-in-refractory-rheumatoid.md)
- [Using MPRA and Human Expression Data to Identify Genetic Mechanisms in Juvenile Idiopathic Arthrit](https://medichelpline.com/clinical-feed/medrxiv-16-combining-a-massively-parallel-reporter-assay-and-human-data-to-elucidate.md)
- [CD19 CAR T-cell therapy (mivocabtagene autoleucel) in refractory seropositive rheumatoid arthritis](https://medichelpline.com/clinical-feed/nature-1-cd19-car-t-cell-therapy-for-treatment-refractory-seropositive-rheumatoid.md)
- [Monocyte reprogramming after autologous stem cell transplantation in juvenile systemic sclerosis:](https://medichelpline.com/clinical-feed/biorxiv-4-longitudinal-single-cell-modeling-reveals-monocyte-reprogramming-in-juvenile.md)

## Navigation
- [← Back to Rheumatology Feed](https://medichelpline.com/clinical-feed/rheumatology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.